Adefovir
In the US, Adefovir (adefovir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B.
US matches:
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0106941-25-7
Chemical Formula
C8-H12-N5-O4-P
Molecular Weight
273
Therapeutic Categories
Antiviral agent
Treatment of hepatitis B
Nucleotide reverse transcriptase inhibitor (NtRTI)
Chemical Name
[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid (WHO)
Foreign Names
- Adefovirum (Latin)
- Adefovir (German)
- Adéfovir (French)
- Adefovir (Spanish)
Generic Names
- Adefovir (OS: BAN, USAN)
- GS 0393 (IS)
- Adefovir Dipivoxil (OS: USAN, BANM)
- Adefovir Pivoxil (OS: JAN)
- Bis (pom) PMEA (IS)
- GS 0840 (IS: GileadSciences)
- Piv2 PMEA (IS)
- Preveon (IS: Bristol-Myers)
Brand Names
- Hepsera
Gilead, Tunisia - A Di Xian
The United Laboratories Ltd, China - A Gan Ding
Fujian Guangsheng Tang, China - Adefovir Stada
Stada-VN JV, Vietnam - Adesera
Cipla, India - Adfovir
Sun Pharma, Myanmar; Sun Pharmaceutical Industries Ltd, Malaysia - Ailuwei
Changzheng-Xinkai, China - Antiva
Square, Bangladesh - Biovir
Ivax, Argentina - Dai Ding
Tianjin Institute of Pharmaceutical Research Pharmaceutical, China - Dinghe
Lukang, China - Hepsera
Gilead, Austria; Gilead, Australia; Gilead, Canada; Gilead, Switzerland; Gilead, Czech Republic; Gilead, Germany; Gilead, Denmark; Gilead, Spain; Gilead, Finland; Gilead, France; Gilead, United Kingdom; Gilead, Greece; Gilead, Hungary; Gilead, Ireland; Gilead, Iceland; Gilead, Italy; Gilead, Lithuania; Gilead, Luxembourg; Gilead, Latvia; Gilead, Netherlands; Gilead, Norway; Gilead, New Zealand; Gilead, Poland; Gilead, Portugal; Gilead, Romania; Gilead, Sweden; Gilead, Slovenia; Gilead, Slovakia; Gilead, Turkey; Gilead, United States; GlaxoSmithKline, Argentina; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Japan; GlaxoSmithKline, South Korea; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Singapore; GlaxoSmithKline, Thailand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline, Vietnam; Patheon UK Limited, Israel; UCB, Belgium - Infovir
Incepta, Bangladesh - Jiule
Fovir Pharm, China - Lifuzhi
Jiangsu TianShiLi BeiTe Pharmaceutical Co., Ltd., China - Ming Zheng
Chia Tai Tianqing, China - Nafasera
Vidipha, Vietnam - Pymefovir
PMP, Vietnam - Xinfunuo
SL Pharm, China - Yilaifen
Qilu, China - Youheding
YSY Pharmaceutical, China - Yubao
Xinghu Biochem Pharm, China
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
